A complications-based clinical staging of obesity to guide treatment modality and intensity
- 1 October 2013
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Endocrinology, Diabetes and Obesity
- Vol. 20 (5), 377-388
- https://doi.org/10.1097/01.med.0000433067.01671.f5
Abstract
Purpose of review The current medical model for obesity management is BMI-centric because BMI is the predominant measure used to gauge disease severity, as well as indications for various treatment modalities. Recent advancements in therapy and understanding of the relationship between BMI and obesity-related complications call for a re-examination of this approach. Recent findings Advancements in treatment, including the recent approval of two new weight loss medications in the USA, have enabled development of new medical models for management of obesity. On the basis of accumulating data demonstrating the benefits of weight loss regarding multiple obesity-related complications (e.g., diabetes prevention, type 2 diabetes mellitus, cardiovascular disease risk, nonalcoholic steatohepatitis, sleep apnea), a complications-centric model is proposed that employs weight loss as a tool to treat and prevent obesity comorbidities. This model assures that the aggressiveness of therapy is commensurate with disease severity, and that therapy is directed at those obese patients who will benefit most from weight loss therapy. The treatment algorithm is comprehensive in addressing complications and quantitative when possible in the staging of risk or disease severity. Summary A complications-centric approach to obesity management identifies patients who will benefit most from weight loss, and optimizes patient outcomes, benefit/risk ratio, and the cost–effectiveness of interventions.Keywords
This publication has 113 references indexed in Scilit:
- Lifestyle intervention and/or statins for the reduction of C‐reactive protein in type 2 diabetes: From the look AHEAD studyObesity, 2013
- Controlled‐Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)Obesity, 2012
- Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studiesThe Lancet, 2011
- Cognitive–behavioral therapy, behavioral weight loss, and sequential treatment for obese patients with binge-eating disorder: A randomized controlled trial.Journal of Consulting and Clinical Psychology, 2011
- Body-Mass Index and Mortality among 1.46 Million White AdultsThe New England Journal of Medicine, 2010
- Epidemiology of OsteoarthritisClinics in Geriatric Medicine, 2010
- A Randomized Study on the Effect of Weight Loss on Obstructive Sleep Apnea Among Obese Patients With Type 2 DiabetesThe Sleep AHEAD StudyEffect of Weight Loss on Obstructive Sleep ApneaJAMA Internal Medicine, 2009
- Weight Loss to Treat Urinary Incontinence in Overweight and Obese WomenThe New England Journal of Medicine, 2009
- Effect of 6‐Month Calorie Restriction and Exercise on Serum and Liver Lipids and Markers of Liver FunctionObesity, 2008
- The Look AHEAD Study: A Description of the Lifestyle Intervention and the Evidence Supporting ItObesity, 2006